{
  "prompt_id": "stage_c_03",
  "stage": "C",
  "generated_at": "2025-10-31T19:47:09.129217Z",
  "metrics": {
    "tool_routing": {
      "score": 0.0,
      "details": {
        "expected": [
          "research_guidelines"
        ],
        "observed": [
          "web_search"
        ],
        "missing": [
          "research_guidelines"
        ],
        "extra": [
          "web_search"
        ]
      }
    },
    "citation_validity": {
      "score": 1.0,
      "details": {
        "total_count": 18,
        "scholarly_count": 6,
        "guideline_count": 0,
        "portal_count": 0,
        "other_count": 12,
        "malformed_count": 0,
        "domain_config_digest": "81cdd2fb63c3b437b7a1fba0f2304715e28ac3b4c5f400507ad7a352bb78c367"
      },
      "citations": [
        {
          "id": "P1",
          "title": "Externally validated and clinically useful machine learning algorithms to support patient-related decision-making in oncology: a scoping review",
          "url": "https://bmcmedresmethodol.biomedcentral.com/articles/10.1186/s12874-025-02463-y",
          "domain": "bmcmedresmethodol.biomedcentral.com",
          "kind": "other",
          "malformed": false
        },
        {
          "id": "P2",
          "title": "A machine learning approach for multimodal data fusion for survival prediction in cancer patients",
          "url": "https://www.nature.com/articles/s41698-025-00917-6",
          "domain": "nature.com",
          "kind": "scholarly",
          "malformed": false
        },
        {
          "id": "P4",
          "title": "Radiomics Quality Score 2.0: towards radiomics readiness levels and clinical translation for personalized medicine",
          "url": "https://www.nature.com/articles/s41571-025-01067-1",
          "domain": "nature.com",
          "kind": "scholarly",
          "malformed": false
        },
        {
          "id": "P5",
          "title": "Biology-guided deep learning predicts prognosis and cancer immunotherapy response",
          "url": "https://www.nature.com/articles/s41467-023-40890-x.pdf",
          "domain": "nature.com",
          "kind": "scholarly",
          "malformed": false
        },
        {
          "id": "P7",
          "title": "Integration of clinical, pathological, radiological, and transcriptomic data improves prediction for first-line immunotherapy outcome in metastatic non-small cell lung cancer",
          "url": "https://www.nature.com/articles/s41467-025-55847-5",
          "domain": "nature.com",
          "kind": "scholarly",
          "malformed": false
        },
        {
          "id": "P8",
          "title": "Prediction of checkpoint inhibitor immunotherapy efficacy for cancer using routine blood tests and clinical data",
          "url": "https://www.nature.com/articles/s41591-024-03398-5",
          "domain": "nature.com",
          "kind": "scholarly",
          "malformed": false
        },
        {
          "id": "1",
          "title": "TRIPOD+AI statement: updated guidance for reporting clinical prediction models using AI/ML",
          "url": "https://www.bmj.com/content/385/bmj-2023-078378",
          "domain": "bmj.com",
          "kind": "other",
          "malformed": false
        },
        {
          "id": "2",
          "title": "PROBAST-AI: updated risk of bias and applicability tool for AI-driven prediction models",
          "url": "https://www.bmj.com/content/388/bmj-2024-082505",
          "domain": "bmj.com",
          "kind": "other",
          "malformed": false
        },
        {
          "id": "3",
          "title": "PROBAST: a tool to assess risk of bias and applicability of prediction model studies",
          "url": "https://pubmed.ncbi.nlm.nih.gov/30596875/",
          "domain": "pubmed.ncbi.nlm.nih.gov",
          "kind": "other",
          "malformed": false
        },
        {
          "id": "4",
          "title": "CONSORT-AI Extension",
          "url": "https://www.equator-network.org/reporting-guidelines/consort-artificial-intelligence/",
          "domain": "equator-network.org",
          "kind": "other",
          "malformed": false
        },
        {
          "id": "5",
          "title": "SPIRIT-AI: guidelines for clinical trial protocols for interventions involving AI",
          "url": "https://www.nature.com/articles/s41591-020-1037-7",
          "domain": "nature.com",
          "kind": "scholarly",
          "malformed": false
        },
        {
          "id": "6",
          "title": "Vickers AJ, Elkin EB. Decision Curve Analysis: A Novel Method for Evaluating Prediction Models",
          "url": "https://journals.sagepub.com/doi/10.1177/0272989X06295361",
          "domain": "journals.sagepub.com",
          "kind": "other",
          "malformed": false
        },
        {
          "id": "7",
          "title": "A simple, step-by-step guide to interpreting decision curve analysis",
          "url": "https://diagnprognres.biomedcentral.com/articles/10.1186/s41512-019-0064-7",
          "domain": "diagnprognres.biomedcentral.com",
          "kind": "other",
          "malformed": false
        },
        {
          "id": "8",
          "title": "The Cancer Imaging Archive (TCIA)",
          "url": "https://www.cancerimagingarchive.net/",
          "domain": "cancerimagingarchive.net",
          "kind": "other",
          "malformed": false
        },
        {
          "id": "9",
          "title": "The Cancer Genome Atlas (TCGA)",
          "url": "https://www.cancer.gov/ccg/research/genome-sequencing/tcga",
          "domain": "cancer.gov",
          "kind": "other",
          "malformed": false
        },
        {
          "id": "10",
          "title": "CPTAC collections (WSI/radiology)",
          "url": "https://www.cancerimagingarchive.net/collection/cptac-cm/",
          "domain": "cancerimagingarchive.net",
          "kind": "other",
          "malformed": false
        },
        {
          "id": "11",
          "title": "METABRIC dataset (Synapse)",
          "url": "https://www.synapse.org/Synapse:syn1688369",
          "domain": "synapse.org",
          "kind": "other",
          "malformed": false
        },
        {
          "id": "12",
          "title": "IMvigor210 Data Access (EGA DAC)",
          "url": "https://ega-archive.org/dacs/EGAC00001001611",
          "domain": "ega-archive.org",
          "kind": "other",
          "malformed": false
        }
      ],
      "legacy_quality_score": 63.333333333333336,
      "legacy_validator": {
        "valid": false,
        "valid_count": 0,
        "total_count": 18,
        "issues": [
          "Citation 1: No authors specified",
          "Citation 1: Invalid or missing year",
          "Citation 1: No venue specified",
          "Citation 1: No meaningful snippet",
          "Citation 2: No authors specified",
          "Citation 2: Invalid or missing year",
          "Citation 2: No venue specified",
          "Citation 2: No DOI available",
          "Citation 2: No meaningful snippet",
          "Citation 3: No authors specified",
          "Citation 3: Invalid or missing year",
          "Citation 3: No venue specified",
          "Citation 3: No DOI available",
          "Citation 3: No meaningful snippet",
          "Citation 4: No authors specified",
          "Citation 4: Invalid or missing year",
          "Citation 4: No venue specified",
          "Citation 4: No DOI available",
          "Citation 4: No meaningful snippet",
          "Citation 5: No authors specified",
          "Citation 5: Invalid or missing year",
          "Citation 5: No venue specified",
          "Citation 5: No DOI available",
          "Citation 5: No meaningful snippet",
          "Citation 6: No authors specified",
          "Citation 6: Invalid or missing year",
          "Citation 6: No venue specified",
          "Citation 6: No DOI available",
          "Citation 6: No meaningful snippet",
          "Citation 7: No authors specified",
          "Citation 7: Invalid or missing year",
          "Citation 7: No venue specified",
          "Citation 7: No DOI available",
          "Citation 7: No meaningful snippet",
          "Citation 8: No authors specified",
          "Citation 8: Invalid or missing year",
          "Citation 8: No venue specified",
          "Citation 8: No DOI available",
          "Citation 8: No meaningful snippet",
          "Citation 9: No authors specified",
          "Citation 9: Invalid or missing year",
          "Citation 9: No venue specified",
          "Citation 9: No DOI available",
          "Citation 9: No meaningful snippet",
          "Citation 10: No authors specified",
          "Citation 10: Invalid or missing year",
          "Citation 10: No venue specified",
          "Citation 10: No DOI available",
          "Citation 10: No meaningful snippet",
          "Citation 11: No authors specified",
          "Citation 11: Invalid or missing year",
          "Citation 11: No venue specified",
          "Citation 11: No DOI available",
          "Citation 11: No meaningful snippet",
          "Citation 12: No authors specified",
          "Citation 12: Invalid or missing year",
          "Citation 12: No venue specified",
          "Citation 12: No meaningful snippet",
          "Citation 13: No authors specified",
          "Citation 13: Invalid or missing year",
          "Citation 13: No venue specified",
          "Citation 13: No meaningful snippet",
          "Citation 14: No authors specified",
          "Citation 14: Invalid or missing year",
          "Citation 14: No venue specified",
          "Citation 14: No DOI available",
          "Citation 14: No meaningful snippet",
          "Citation 15: No authors specified",
          "Citation 15: Invalid or missing year",
          "Citation 15: No venue specified",
          "Citation 15: No DOI available",
          "Citation 15: No meaningful snippet",
          "Citation 16: No authors specified",
          "Citation 16: Invalid or missing year",
          "Citation 16: No venue specified",
          "Citation 16: No DOI available",
          "Citation 16: No meaningful snippet",
          "Citation 17: No authors specified",
          "Citation 17: Invalid or missing year",
          "Citation 17: No venue specified",
          "Citation 17: No DOI available",
          "Citation 17: No meaningful snippet",
          "Citation 18: No authors specified",
          "Citation 18: Invalid or missing year",
          "Citation 18: No venue specified",
          "Citation 18: No DOI available",
          "Citation 18: No meaningful snippet"
        ],
        "individual_results": [
          {
            "valid": false,
            "score": 65.0,
            "issues": [
              "No authors specified",
              "Invalid or missing year",
              "No venue specified",
              "No meaningful snippet"
            ],
            "completeness": 42.857142857142854
          },
          {
            "valid": false,
            "score": 63.0,
            "issues": [
              "No authors specified",
              "Invalid or missing year",
              "No venue specified",
              "No DOI available",
              "No meaningful snippet"
            ],
            "completeness": 28.57142857142857
          },
          {
            "valid": false,
            "score": 63.0,
            "issues": [
              "No authors specified",
              "Invalid or missing year",
              "No venue specified",
              "No DOI available",
              "No meaningful snippet"
            ],
            "completeness": 28.57142857142857
          },
          {
            "valid": false,
            "score": 63.0,
            "issues": [
              "No authors specified",
              "Invalid or missing year",
              "No venue specified",
              "No DOI available",
              "No meaningful snippet"
            ],
            "completeness": 28.57142857142857
          },
          {
            "valid": false,
            "score": 63.0,
            "issues": [
              "No authors specified",
              "Invalid or missing year",
              "No venue specified",
              "No DOI available",
              "No meaningful snippet"
            ],
            "completeness": 28.57142857142857
          },
          {
            "valid": false,
            "score": 63.0,
            "issues": [
              "No authors specified",
              "Invalid or missing year",
              "No venue specified",
              "No DOI available",
              "No meaningful snippet"
            ],
            "completeness": 28.57142857142857
          },
          {
            "valid": false,
            "score": 63.0,
            "issues": [
              "No authors specified",
              "Invalid or missing year",
              "No venue specified",
              "No DOI available",
              "No meaningful snippet"
            ],
            "completeness": 28.57142857142857
          },
          {
            "valid": false,
            "score": 63.0,
            "issues": [
              "No authors specified",
              "Invalid or missing year",
              "No venue specified",
              "No DOI available",
              "No meaningful snippet"
            ],
            "completeness": 28.57142857142857
          },
          {
            "valid": false,
            "score": 63.0,
            "issues": [
              "No authors specified",
              "Invalid or missing year",
              "No venue specified",
              "No DOI available",
              "No meaningful snippet"
            ],
            "completeness": 28.57142857142857
          },
          {
            "valid": false,
            "score": 63.0,
            "issues": [
              "No authors specified",
              "Invalid or missing year",
              "No venue specified",
              "No DOI available",
              "No meaningful snippet"
            ],
            "completeness": 28.57142857142857
          },
          {
            "valid": false,
            "score": 63.0,
            "issues": [
              "No authors specified",
              "Invalid or missing year",
              "No venue specified",
              "No DOI available",
              "No meaningful snippet"
            ],
            "completeness": 28.57142857142857
          },
          {
            "valid": false,
            "score": 65.0,
            "issues": [
              "No authors specified",
              "Invalid or missing year",
              "No venue specified",
              "No meaningful snippet"
            ],
            "completeness": 42.857142857142854
          },
          {
            "valid": false,
            "score": 65.0,
            "issues": [
              "No authors specified",
              "Invalid or missing year",
              "No venue specified",
              "No meaningful snippet"
            ],
            "completeness": 42.857142857142854
          },
          {
            "valid": false,
            "score": 63.0,
            "issues": [
              "No authors specified",
              "Invalid or missing year",
              "No venue specified",
              "No DOI available",
              "No meaningful snippet"
            ],
            "completeness": 28.57142857142857
          },
          {
            "valid": false,
            "score": 63.0,
            "issues": [
              "No authors specified",
              "Invalid or missing year",
              "No venue specified",
              "No DOI available",
              "No meaningful snippet"
            ],
            "completeness": 28.57142857142857
          },
          {
            "valid": false,
            "score": 63.0,
            "issues": [
              "No authors specified",
              "Invalid or missing year",
              "No venue specified",
              "No DOI available",
              "No meaningful snippet"
            ],
            "completeness": 28.57142857142857
          },
          {
            "valid": false,
            "score": 63.0,
            "issues": [
              "No authors specified",
              "Invalid or missing year",
              "No venue specified",
              "No DOI available",
              "No meaningful snippet"
            ],
            "completeness": 28.57142857142857
          },
          {
            "valid": false,
            "score": 63.0,
            "issues": [
              "No authors specified",
              "Invalid or missing year",
              "No venue specified",
              "No DOI available",
              "No meaningful snippet"
            ],
            "completeness": 28.57142857142857
          }
        ]
      }
    },
    "fallback_robustness": {
      "score": 0.0
    },
    "rag_fidelity": {
      "score": 2.0,
      "judges": [
        {
          "judge": "openrouter:google/gemini-2.5-flash",
          "raw": "```json\n{\n \"score\": 2.0,\n \"rationale\": \"The agent accurately synthesizes information from the provided citations to construct a comprehensive and realistic plan for using AI in cancer research. It correctly identifies the infeasibility of a 'tomorrow' cure and instead proposes a 6-month plan focused on clinically meaningful improvements, aligning with the evidence that few oncology ML models achieve external validation and clinical utility [P1].\\n\\nThe agent attributes specific claims to the correct sources, such as prioritizing external validation and clinical utility [P1], the use of routine clinical data for checkpoint inhibitor benefit prediction [P8], and the benefits of multimodal fusion [P2]. It also correctly cites guidelines for reporting and bias assessment (TRIPOD-AI/PROBAST-AI) [1, 2] and specific datasets (TCGA/CPTAC/TCIA/METABRIC) [8, 9, 10, 11].\\n\\nThere are no contradictions or fabrications. The plan is well-structured, detailing objectives, experiments, and a timeline, all grounded in the cited evidence.\",\n \"confidence\": \"high\"\n}\n```",
          "rationale": "The agent accurately synthesizes information from the provided citations to construct a comprehensive and realistic plan for using AI in cancer research. It correctly identifies the infeasibility of a 'tomorrow' cure and instead proposes a 6-month plan focused on clinically meaningful improvements, aligning with the evidence that few oncology ML models achieve external validation and clinical utility [P1].\n\nThe agent attributes specific claims to the correct sources, such as prioritizing external validation and clinical utility [P1], the use of routine clinical data for checkpoint inhibitor benefit prediction [P8], and the benefits of multimodal fusion [P2]. It also correctly cites guidelines for reporting and bias assessment (TRIPOD-AI/PROBAST-AI) [1, 2] and specific datasets (TCGA/CPTAC/TCIA/METABRIC) [8, 9, 10, 11].\n\nThere are no contradictions or fabrications. The plan is well-structured, detailing objectives, experiments, and a timeline, all grounded in the cited evidence.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 6621,
            "output_tokens": 244,
            "total_tokens": 6865,
            "input_token_details": {
              "cache_read": 0
            },
            "output_token_details": {
              "reasoning": 0
            }
          },
          "score": 2.0
        },
        {
          "judge": "openrouter:deepseek/deepseek-v3.2-exp",
          "raw": "{\n  \"score\": 2.0,\n  \"rationale\": \"The response synthesizes cited evidence accurately with clear attribution throughout, directly referencing specific sources (e.g., P1, P2, P4, P5, P7, P8, 1-12) to support claims about feasibility, multimodal data fusion, validation requirements, clinical utility metrics, and reporting guidelines. It maintains consistency with the evidence summary and extracted citations, addressing the user's unrealistic timeline by proposing a realistic 6-month plan grounded in current research gaps and methodological standards without contradictions.\",\n  \"confidence\": \"high\"\n}",
          "rationale": "The response synthesizes cited evidence accurately with clear attribution throughout, directly referencing specific sources (e.g., P1, P2, P4, P5, P7, P8, 1-12) to support claims about feasibility, multimodal data fusion, validation requirements, clinical utility metrics, and reporting guidelines. It maintains consistency with the evidence summary and extracted citations, addressing the user's unrealistic timeline by proposing a realistic 6-month plan grounded in current research gaps and methodological standards without contradictions.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 5531,
            "output_tokens": 125,
            "total_tokens": 5656,
            "input_token_details": {},
            "output_token_details": {}
          },
          "score": 2.0
        },
        {
          "judge": "openrouter:x-ai/grok-4-fast",
          "raw": "{\"score\": 2.0, \"rationale\": \"The response accurately synthesizes cited evidence from sources like [P1] (scoping review on oncology ML validation gaps), [P8] (routine data for ICI prediction), [P2] (multimodal fusion benefits), and guidelines ([1], [2], etc.) with clear in-text attributions (e.g., 'similar to recent multi-center findings [P8]') and no contradictions or fabrications; all claims are directly grounded in the retrieved evidence without omissions impacting fidelity.\", \"confidence\": \"high\"}",
          "rationale": "The response accurately synthesizes cited evidence from sources like [P1] (scoping review on oncology ML validation gaps), [P8] (routine data for ICI prediction), [P2] (multimodal fusion benefits), and guidelines ([1], [2], etc.) with clear in-text attributions (e.g., 'similar to recent multi-center findings [P8]') and no contradictions or fabrications; all claims are directly grounded in the retrieved evidence without omissions impacting fidelity.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 5495,
            "output_tokens": 600,
            "total_tokens": 6095,
            "input_token_details": {},
            "output_token_details": {
              "reasoning": 483
            }
          },
          "score": 2.0
        }
      ]
    },
    "citation_relevance": {
      "score": 2.0,
      "judges": [
        {
          "judge": "openrouter:google/gemini-2.5-flash",
          "raw": "```json\n{\n \"score\": 2.0,\n \"rationale\": \"All citations directly support the claims made in the response. The response frequently references specific citations (e.g., [P1], [P8], [1], [2]) to back up statements about the feasibility of AI in cancer, specific methodologies, data sources, and reporting standards. The citations are highly relevant to the technical and methodological aspects of the proposed plan.\",\n \"confidence\": \"high\"\n}\n```",
          "rationale": "All citations directly support the claims made in the response. The response frequently references specific citations (e.g., [P1], [P8], [1], [2]) to back up statements about the feasibility of AI in cancer, specific methodologies, data sources, and reporting standards. The citations are highly relevant to the technical and methodological aspects of the proposed plan.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 6582,
            "output_tokens": 104,
            "total_tokens": 6686,
            "input_token_details": {
              "cache_read": 0
            },
            "output_token_details": {
              "reasoning": 0
            }
          },
          "score": 2.0
        },
        {
          "judge": "openrouter:deepseek/deepseek-v3.2-exp",
          "raw": "{\n  \"score\": 2.0,\n  \"rationale\": \"All citations directly support specific claims in the response. For example: [P1] supports the claim about external validation gaps; [P8] supports using routine clinical data for immunotherapy prediction; [P2] supports multimodal fusion superiority; [P4] supports radiomics standards; [P5] supports biology-guided histology; [1][2][4][5] support reporting guidelines; [6][7] support decision-curve analysis; and [8][9][10][11][12] support data source recommendations. Each citation is precisely aligned with the technical assertions made.\",\n  \"confidence\": \"high\"\n}",
          "rationale": "All citations directly support specific claims in the response. For example: [P1] supports the claim about external validation gaps; [P8] supports using routine clinical data for immunotherapy prediction; [P2] supports multimodal fusion superiority; [P4] supports radiomics standards; [P5] supports biology-guided histology; [1][2][4][5] support reporting guidelines; [6][7] support decision-curve analysis; and [8][9][10][11][12] support data source recommendations. Each citation is precisely aligned with the technical assertions made.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 5494,
            "output_tokens": 142,
            "total_tokens": 5636,
            "input_token_details": {},
            "output_token_details": {}
          },
          "score": 2.0
        },
        {
          "judge": "openrouter:x-ai/grok-4-fast",
          "raw": "{\"score\": 2.0, \"rationale\": \"Citations directly support claims throughout the response; for example, [P1] backs the scoping review on external validation gaps in oncology ML models, [P8] supports predictions of immunotherapy benefit from routine data, [P2] evidences multimodal fusion outperforming single-modality models, and guidelines like [1] and [2] directly inform reporting and bias assessment standards per TRIPOD-AI/PROBAST-AI. Data sources ([8]-[12]) are precisely relevant to cohort setups. No irrelevant citations observed.\", \"confidence\": \"high\"}",
          "rationale": "Citations directly support claims throughout the response; for example, [P1] backs the scoping review on external validation gaps in oncology ML models, [P8] supports predictions of immunotherapy benefit from routine data, [P2] evidences multimodal fusion outperforming single-modality models, and guidelines like [1] and [2] directly inform reporting and bias assessment standards per TRIPOD-AI/PROBAST-AI. Data sources ([8]-[12]) are precisely relevant to cohort setups. No irrelevant citations observed.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 5458,
            "output_tokens": 510,
            "total_tokens": 5968,
            "input_token_details": {},
            "output_token_details": {
              "reasoning": 386
            }
          },
          "score": 2.0
        }
      ]
    },
    "source_fit": {
      "score": 2.0,
      "judges": [
        {
          "judge": "openrouter:google/gemini-2.5-flash",
          "raw": "```json\n{\n \"score\": 2.0,\n \"rationale\": \"The sources provided are highly appropriate for the user's goal and expertise. The user is asking for a plan to 'cure cancer with AI tomorrow,' which implies a high level of ambition and a need for cutting-edge information. The agent correctly identifies this as an infeasible goal and reframes it into a realistic 6-month plan for research and development in AI for cancer treatment. The sources cited are primarily recent (many from 2023-2025) scholarly articles from reputable journals (Nature, BMJ, BMC Medical Research Methodology) and well-known cancer data repositories (TCGA, CPTAC, TCIA, METABRIC). These sources cover relevant topics such as reporting guidelines for AI in clinical prediction models (TRIPOD-AI, PROBAST-AI, CONSORT-AI, SPIRIT-AI), multimodal data fusion for survival prediction, radiomics quality scores, biology-guided deep learning, and prediction of immunotherapy efficacy using routine data. This selection demonstrates a deep understanding of the current state-of-the-art in AI for oncology and provides a solid foundation for the proposed plan.\",\n \"confidence\": \"high\"\n}\n```",
          "rationale": "The sources provided are highly appropriate for the user's goal and expertise. The user is asking for a plan to 'cure cancer with AI tomorrow,' which implies a high level of ambition and a need for cutting-edge information. The agent correctly identifies this as an infeasible goal and reframes it into a realistic 6-month plan for research and development in AI for cancer treatment. The sources cited are primarily recent (many from 2023-2025) scholarly articles from reputable journals (Nature, BMJ, BMC Medical Research Methodology) and well-known cancer data repositories (TCGA, CPTAC, TCIA, METABRIC). These sources cover relevant topics such as reporting guidelines for AI in clinical prediction models (TRIPOD-AI, PROBAST-AI, CONSORT-AI, SPIRIT-AI), multimodal data fusion for survival prediction, radiomics quality scores, biology-guided deep learning, and prediction of immunotherapy efficacy using routine data. This selection demonstrates a deep understanding of the current state-of-the-art in AI for oncology and provides a solid foundation for the proposed plan.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 6591,
            "output_tokens": 257,
            "total_tokens": 6848,
            "input_token_details": {
              "cache_read": 0
            },
            "output_token_details": {
              "reasoning": 0
            }
          },
          "score": 2.0
        },
        {
          "judge": "openrouter:deepseek/deepseek-v3.2-exp",
          "raw": "{\n  \"score\": 2.0,\n  \"rationale\": \"The response uses highly appropriate sources for the user's goal of applying AI to cancer treatment, citing recent (2024-2025) high-impact journals (Nature, BMJ) and specific clinical guidelines (TRIPOD-AI, PROBAST-AI, CONSORT-AI) that are directly relevant to developing clinically meaningful AI models. Sources address key gaps in oncology AI (external validation, clinical utility) and provide practical methodologies aligned with current evidence standards, making them optimal for the user's expertise level and ambitious goal.\",\n  \"confidence\": \"high\"\n}",
          "rationale": "The response uses highly appropriate sources for the user's goal of applying AI to cancer treatment, citing recent (2024-2025) high-impact journals (Nature, BMJ) and specific clinical guidelines (TRIPOD-AI, PROBAST-AI, CONSORT-AI) that are directly relevant to developing clinically meaningful AI models. Sources address key gaps in oncology AI (external validation, clinical utility) and provide practical methodologies aligned with current evidence standards, making them optimal for the user's expertise level and ambitious goal.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 5503,
            "output_tokens": 129,
            "total_tokens": 5632,
            "input_token_details": {},
            "output_token_details": {}
          },
          "score": 2.0
        },
        {
          "judge": "openrouter:x-ai/grok-4-fast",
          "raw": "{\"score\": 2.0, \"rationale\": \"The sources are highly appropriate for the user's goal of developing an AI plan for cancer treatment advancements, featuring recent publications (2023-2025) from prestigious venues like Nature, BMJ, and BMC, as well as foundational guidelines (e.g., TRIPOD+AI 2024) and data repositories (e.g., TCGA). They directly address ML model validation, multimodal fusion, and clinical utility in oncology, matching the reframed feasible plan while suiting a motivated but potentially novice user's expertise through accessible integration.\", \"confidence\": \"high\"}",
          "rationale": "The sources are highly appropriate for the user's goal of developing an AI plan for cancer treatment advancements, featuring recent publications (2023-2025) from prestigious venues like Nature, BMJ, and BMC, as well as foundational guidelines (e.g., TRIPOD+AI 2024) and data repositories (e.g., TCGA). They directly address ML model validation, multimodal fusion, and clinical utility in oncology, matching the reframed feasible plan while suiting a motivated but potentially novice user's expertise through accessible integration.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 5465,
            "output_tokens": 584,
            "total_tokens": 6049,
            "input_token_details": {},
            "output_token_details": {
              "reasoning": 461
            }
          },
          "score": 2.0
        }
      ]
    },
    "citation_quality": {
      "score": 2.0,
      "judges": [
        {
          "judge": "openrouter:google/gemini-2.5-flash",
          "raw": "```json\n{\n \"score\": 2.0,\n \"rationale\": \"All citations are real, well-formatted, and directly support the claims made in the response. The citations include scholarly articles from reputable journals (e.g., Nature, BMJ, BMC Medical Research Methodology) and authoritative portals (e.g., The Cancer Imaging Archive, The Cancer Genome Atlas). They are used to back up specific statements about research findings, methodologies, and data sources.\",\n \"confidence\": \"high\"\n}\n```",
          "rationale": "All citations are real, well-formatted, and directly support the claims made in the response. The citations include scholarly articles from reputable journals (e.g., Nature, BMJ, BMC Medical Research Methodology) and authoritative portals (e.g., The Cancer Imaging Archive, The Cancer Genome Atlas). They are used to back up specific statements about research findings, methodologies, and data sources.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 6619,
            "output_tokens": 108,
            "total_tokens": 6727,
            "input_token_details": {
              "cache_read": 0
            },
            "output_token_details": {
              "reasoning": 0
            }
          },
          "score": 2.0
        },
        {
          "judge": "openrouter:deepseek/deepseek-v3.2-exp",
          "raw": "{\n  \"score\": 2.0,\n  \"rationale\": \"All citations are real, well-formatted with complete URLs and descriptive titles, and directly support claims with authoritative sources including Nature, BMJ, BMC journals, and established biomedical databases/portals (TCGA, TCIA, CPTAC, METABRIC, EGA). Citations are consistently relevant to specific methodological claims about prediction models, validation, reporting guidelines, and clinical utility in oncology AI.\",\n  \"confidence\": \"high\"\n}",
          "rationale": "All citations are real, well-formatted with complete URLs and descriptive titles, and directly support claims with authoritative sources including Nature, BMJ, BMC journals, and established biomedical databases/portals (TCGA, TCIA, CPTAC, METABRIC, EGA). Citations are consistently relevant to specific methodological claims about prediction models, validation, reporting guidelines, and clinical utility in oncology AI.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 5531,
            "output_tokens": 102,
            "total_tokens": 5633,
            "input_token_details": {},
            "output_token_details": {}
          },
          "score": 2.0
        },
        {
          "judge": "openrouter:x-ai/grok-4-fast",
          "raw": "{\"score\": 2.0, \"rationale\": \"All citations are real, from authoritative scholarly sources (e.g., Nature, BMJ, BMC) or official portals (e.g., NCI, TCIA), well-formatted with titles and direct URLs, and directly support claims such as ML validation gaps [P1], multimodal fusion benefits [P2], reporting guidelines [1][2], and dataset access [8-12]. No missing, fabricated, or irrelevant citations observed.\", \"confidence\": \"high\"}",
          "rationale": "All citations are real, from authoritative scholarly sources (e.g., Nature, BMJ, BMC) or official portals (e.g., NCI, TCIA), well-formatted with titles and direct URLs, and directly support claims such as ML validation gaps [P1], multimodal fusion benefits [P2], reporting guidelines [1][2], and dataset access [8-12]. No missing, fabricated, or irrelevant citations observed.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 5492,
            "output_tokens": 743,
            "total_tokens": 6235,
            "input_token_details": {},
            "output_token_details": {
              "reasoning": 639
            }
          },
          "score": 2.0
        }
      ]
    },
    "actionability": {
      "score": 0.9,
      "judges": [
        {
          "judge": "openrouter:google/gemini-2.5-flash",
          "raw": "```json\n{\n \"score\": 1.0,\n \"rationale\": \"The agent provides an extremely detailed and actionable plan. It breaks down the problem into manageable objectives, outlines specific experiments with hypotheses, setups (data, features, models, validation), baselines, metrics, and expected outcomes. It also includes a clear timeline with milestones for each month. The plan is highly concrete, providing commands (e.g., \\\"Train Experiment 1 and/or 2 models\\\"), parameters (e.g., \\\"Penalized logistic regression, XGBoost, tab-transformer\\\"), and expected outcomes (e.g., \\\"Competitive AUROC with strong calibration\\\"). It even includes an \\\"Optional next step\\\" that further enhances actionability by offering to lock down specifics based on user input.\",\n \"confidence\": \"high\"\n}\n```",
          "rationale": "The agent provides an extremely detailed and actionable plan. It breaks down the problem into manageable objectives, outlines specific experiments with hypotheses, setups (data, features, models, validation), baselines, metrics, and expected outcomes. It also includes a clear timeline with milestones for each month. The plan is highly concrete, providing commands (e.g., \"Train Experiment 1 and/or 2 models\"), parameters (e.g., \"Penalized logistic regression, XGBoost, tab-transformer\"), and expected outcomes (e.g., \"Competitive AUROC with strong calibration\"). It even includes an \"Optional next step\" that further enhances actionability by offering to lock down specifics based on user input.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 6620,
            "output_tokens": 176,
            "total_tokens": 6796,
            "input_token_details": {
              "cache_read": 0
            },
            "output_token_details": {
              "reasoning": 0
            }
          },
          "score": 1.0
        },
        {
          "judge": "openrouter:deepseek/deepseek-v3.2-exp",
          "raw": "{\n  \"score\": 0.8,\n  \"rationale\": \"The response provides clear, structured next steps including specific experiments, data sources, models, validation methods, and a 6-month timeline with milestones, but lacks concrete executable commands or parameters for immediate implementation, leaving minor gaps in direct actionability.\",\n  \"confidence\": \"high\"\n}",
          "rationale": "The response provides clear, structured next steps including specific experiments, data sources, models, validation methods, and a 6-month timeline with milestones, but lacks concrete executable commands or parameters for immediate implementation, leaving minor gaps in direct actionability.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 5533,
            "output_tokens": 72,
            "total_tokens": 5605,
            "input_token_details": {},
            "output_token_details": {}
          },
          "score": 0.8
        },
        {
          "judge": "openrouter:x-ai/grok-4-fast",
          "raw": "{\"score\": 0.9, \"rationale\": \"The response provides concrete executable steps through a structured 6-month plan, including specific experiments with hypotheses, data sources (e.g., TCGA, CPTAC), models (e.g., XGBoost, tab-transformer), features (e.g., CBC/differentials), validation methods (e.g., nested CV, temporal splits), metrics (e.g., AUROC, C-index, IBS), baselines, and expected outcomes (e.g., positive net benefit). The timeline includes monthly milestones like securing IRB agreements and implementing preprocessing pipelines. This aligns closely with 1.0 criteria but has minor gaps, such as lacking literal code commands or scripts, requiring the user to implement technical details, thus slightly below perfect executability.\", \"confidence\": \"high\"}",
          "rationale": "The response provides concrete executable steps through a structured 6-month plan, including specific experiments with hypotheses, data sources (e.g., TCGA, CPTAC), models (e.g., XGBoost, tab-transformer), features (e.g., CBC/differentials), validation methods (e.g., nested CV, temporal splits), metrics (e.g., AUROC, C-index, IBS), baselines, and expected outcomes (e.g., positive net benefit). The timeline includes monthly milestones like securing IRB agreements and implementing preprocessing pipelines. This aligns closely with 1.0 criteria but has minor gaps, such as lacking literal code commands or scripts, requiring the user to implement technical details, thus slightly below perfect executability.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 5496,
            "output_tokens": 678,
            "total_tokens": 6174,
            "input_token_details": {},
            "output_token_details": {
              "reasoning": 515
            }
          },
          "score": 0.9
        }
      ]
    },
    "persona_compliance": {
      "score": 2.0,
      "judges": [
        {
          "judge": "openrouter:google/gemini-2.5-flash",
          "raw": "```json\n{\n  \"score\": 2.0,\n  \"rationale\": \"The agent consistently maintains an encouraging and guiding mentor persona. It directly addresses the user's ambitious goal by providing a 'reality check' in a supportive way, then immediately pivots to a structured, actionable plan. The language used throughout is professional, informative, and constructive, guiding the user through complex concepts without being dismissive. Phrases like 'your plan should prioritize these gaps' and 'if you can share... I can lock the milestones' demonstrate active mentorship.\",\n  \"confidence\": \"high\"\n}\n```",
          "rationale": "The agent consistently maintains an encouraging and guiding mentor persona. It directly addresses the user's ambitious goal by providing a 'reality check' in a supportive way, then immediately pivots to a structured, actionable plan. The language used throughout is professional, informative, and constructive, guiding the user through complex concepts without being dismissive. Phrases like 'your plan should prioritize these gaps' and 'if you can share... I can lock the milestones' demonstrate active mentorship.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 6590,
            "output_tokens": 126,
            "total_tokens": 6716,
            "input_token_details": {
              "cache_read": 0
            },
            "output_token_details": {
              "reasoning": 0
            }
          },
          "score": 2.0
        },
        {
          "judge": "openrouter:deepseek/deepseek-v3.2-exp",
          "raw": "{\n  \"score\": 2.0,\n  \"rationale\": \"The response consistently maintains an encouraging and guiding mentor persona by first acknowledging the user's ambitious goal with a gentle reality check, then providing a structured, evidence-based 6-month plan with clear objectives, experiments, timelines, and citations. It offers actionable steps, emphasizes clinical utility and validation, and invites further collaboration, aligning with the rubric's criteria for a consistently encouraging and guiding tone.\",\n  \"confidence\": \"high\"\n}",
          "rationale": "The response consistently maintains an encouraging and guiding mentor persona by first acknowledging the user's ambitious goal with a gentle reality check, then providing a structured, evidence-based 6-month plan with clear objectives, experiments, timelines, and citations. It offers actionable steps, emphasizes clinical utility and validation, and invites further collaboration, aligning with the rubric's criteria for a consistently encouraging and guiding tone.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 5501,
            "output_tokens": 100,
            "total_tokens": 5601,
            "input_token_details": {},
            "output_token_details": {}
          },
          "score": 2.0
        },
        {
          "judge": "openrouter:x-ai/grok-4-fast",
          "raw": "{\"score\": 2.0, \"rationale\": \"The response maintains a consistently encouraging and guiding mentor persona by acknowledging the user's ambitious goal with a gentle reality check, then providing a detailed, structured 6-month plan with clear objectives, experiments, timelines, success criteria, and citations to build skills and achieve meaningful progress in oncology AI. It offers further personalized assistance in the optional next step, fostering motivation without dismissing the user's enthusiasm.\", \"confidence\": \"high\"}",
          "rationale": "The response maintains a consistently encouraging and guiding mentor persona by acknowledging the user's ambitious goal with a gentle reality check, then providing a detailed, structured 6-month plan with clear objectives, experiments, timelines, success criteria, and citations to build skills and achieve meaningful progress in oncology AI. It offers further personalized assistance in the optional next step, fostering motivation without dismissing the user's enthusiasm.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 5464,
            "output_tokens": 401,
            "total_tokens": 5865,
            "input_token_details": {},
            "output_token_details": {
              "reasoning": 307
            }
          },
          "score": 2.0
        }
      ]
    },
    "stage_awareness": {
      "score": 2.0,
      "judges": [
        {
          "judge": "openrouter:google/gemini-2.5-flash",
          "raw": "```json\n{\n \"score\": 2.0,\n \"rationale\": \"The user's prompt is highly unrealistic, asking to \\\"cure cancer with AI tomorrow.\\\" The agent immediately addresses this by performing a \\\"reality check\\\" and reframing the goal into a feasible 6-month plan. This demonstrates a clear understanding of the user's initial, unrealistic stage and effectively guides them towards a more practical and achievable research trajectory. The plan is then meticulously detailed, aligning with the reframed, realistic goals.\",\n \"confidence\": \"high\"\n}\n```",
          "rationale": "The user's prompt is highly unrealistic, asking to \"cure cancer with AI tomorrow.\" The agent immediately addresses this by performing a \"reality check\" and reframing the goal into a feasible 6-month plan. This demonstrates a clear understanding of the user's initial, unrealistic stage and effectively guides them towards a more practical and achievable research trajectory. The plan is then meticulously detailed, aligning with the reframed, realistic goals.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 6599,
            "output_tokens": 117,
            "total_tokens": 6716,
            "input_token_details": {
              "cache_read": 0
            },
            "output_token_details": {
              "reasoning": 0
            }
          },
          "score": 2.0
        },
        {
          "judge": "openrouter:deepseek/deepseek-v3.2-exp",
          "raw": "{\n  \"score\": 2.0,\n  \"rationale\": \"The response clearly recognizes the user's unrealistic timeline ('cure cancer with AI tomorrow') and immediately reframes it into a feasible 6-month research plan focused on incremental improvements in treatment prediction and validation, aligning with the user's implied research stage by providing structured, evidence-based guidance tailored to achievable objectives.\",\n  \"confidence\": \"high\"\n}",
          "rationale": "The response clearly recognizes the user's unrealistic timeline ('cure cancer with AI tomorrow') and immediately reframes it into a feasible 6-month research plan focused on incremental improvements in treatment prediction and validation, aligning with the user's implied research stage by providing structured, evidence-based guidance tailored to achievable objectives.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 5511,
            "output_tokens": 84,
            "total_tokens": 5595,
            "input_token_details": {},
            "output_token_details": {}
          },
          "score": 2.0
        },
        {
          "judge": "openrouter:x-ai/grok-4-fast",
          "raw": "{\"score\": 2.0, \"rationale\": \"The response clearly recognizes the user's early, unrealistic ideation stage by providing an explicit reality check on the infeasibility of 'curing cancer with AI tomorrow' and tailors guidance to a practical 6-month plan focused on achievable milestones like problem framing, data access, model development, validation, and reporting, aligning with rubric criteria for stage awareness without jumping ahead.\", \"confidence\": \"high\"}",
          "rationale": "The response clearly recognizes the user's early, unrealistic ideation stage by providing an explicit reality check on the infeasibility of 'curing cancer with AI tomorrow' and tailors guidance to a practical 6-month plan focused on achievable milestones like problem framing, data access, model development, validation, and reporting, aligning with rubric criteria for stage awareness without jumping ahead.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 5472,
            "output_tokens": 464,
            "total_tokens": 5936,
            "input_token_details": {},
            "output_token_details": {
              "reasoning": 374
            }
          },
          "score": 2.0
        }
      ]
    },
    "tone_constructive": {
      "score": 2.0,
      "judges": [
        {
          "judge": "openrouter:google/gemini-2.5-flash",
          "raw": "```json\n{\n  \"score\": 2.0,\n  \"rationale\": \"The agent's response is highly constructive and motivating. It directly addresses the user's ambitious goal by providing a 'reality check' without being dismissive. Instead, it reframes the goal into achievable, clinically meaningful objectives and outlines a detailed, structured plan. The language used is professional, encouraging, and focuses on progress and practical steps. Phrases like 'prioritize these gaps,' 'accelerate clinical translation,' and 'demonstrable improvement' reinforce a positive and forward-looking tone. The 'Optional next step' further demonstrates a willingness to collaborate and refine the plan, which is highly motivating.\",\n  \"confidence\": \"high\"\n}\n```",
          "rationale": "The agent's response is highly constructive and motivating. It directly addresses the user's ambitious goal by providing a 'reality check' without being dismissive. Instead, it reframes the goal into achievable, clinically meaningful objectives and outlines a detailed, structured plan. The language used is professional, encouraging, and focuses on progress and practical steps. Phrases like 'prioritize these gaps,' 'accelerate clinical translation,' and 'demonstrable improvement' reinforce a positive and forward-looking tone. The 'Optional next step' further demonstrates a willingness to collaborate and refine the plan, which is highly motivating.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 6599,
            "output_tokens": 154,
            "total_tokens": 6753,
            "input_token_details": {
              "cache_read": 0
            },
            "output_token_details": {
              "reasoning": 0
            }
          },
          "score": 2.0
        },
        {
          "judge": "openrouter:deepseek/deepseek-v3.2-exp",
          "raw": "{\n  \"score\": 2.0,\n  \"rationale\": \"The response immediately provides a constructive reality check ('Reality check: \\\"Cure cancer with AI tomorrow\\\" is infeasible') while redirecting to achievable, evidence-based goals ('A 6-month, publication-grade plan can target clinically meaningful, measurable improvements'). It maintains a motivating tone by outlining specific, actionable steps and milestones, reinforcing progress through structured experiments and timelines without resorting to fluff or empty encouragement.\",\n  \"confidence\": \"high\"\n}",
          "rationale": "The response immediately provides a constructive reality check ('Reality check: \"Cure cancer with AI tomorrow\" is infeasible') while redirecting to achievable, evidence-based goals ('A 6-month, publication-grade plan can target clinically meaningful, measurable improvements'). It maintains a motivating tone by outlining specific, actionable steps and milestones, reinforcing progress through structured experiments and timelines without resorting to fluff or empty encouragement.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 5513,
            "output_tokens": 108,
            "total_tokens": 5621,
            "input_token_details": {},
            "output_token_details": {}
          },
          "score": 2.0
        },
        {
          "judge": "openrouter:x-ai/grok-4-fast",
          "raw": "{\"score\": 2.0, \"rationale\": \"The agent's response employs a constructive and motivating tone by starting with a straightforward reality check on the infeasibility of curing cancer 'tomorrow' but quickly pivoting to an actionable, evidence-based 6-month plan with clear objectives, experiments, milestones, and success criteria. This reinforces progress toward clinically meaningful advancements without fluff, using encouraging language like 'target clinically meaningful improvements' and offering optional next steps for further support, aligning with the 2.0 rubric criteria.\", \"confidence\": \"high\"}",
          "rationale": "The agent's response employs a constructive and motivating tone by starting with a straightforward reality check on the infeasibility of curing cancer 'tomorrow' but quickly pivoting to an actionable, evidence-based 6-month plan with clear objectives, experiments, milestones, and success criteria. This reinforces progress toward clinically meaningful advancements without fluff, using encouraging language like 'target clinically meaningful improvements' and offering optional next steps for further support, aligning with the 2.0 rubric criteria.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 5472,
            "output_tokens": 466,
            "total_tokens": 5938,
            "input_token_details": {},
            "output_token_details": {
              "reasoning": 355
            }
          },
          "score": 2.0
        }
      ]
    },
    "expectation_management": {
      "score": 1.0,
      "judges": [
        {
          "judge": "openrouter:google/gemini-2.5-flash",
          "raw": "```json\n{\n \"score\": 1,\n \"rationale\": \"The user's prompt is highly unrealistic, asking to \\\"cure cancer with AI tomorrow.\\\" The agent immediately addresses this by stating, \\\"Reality check: 'Cure cancer with AI tomorrow' is infeasible.\\\" It then reframes the goal into a feasible, 6-month plan targeting \\\"clinically meaningful, measurable improvements in treatment selection and outcome prediction.\\\" This directly aligns with the rubric criterion of setting realistic expectations or reframing infeasible goals.\",\n \"confidence\": \"high\"\n}\n```",
          "rationale": "The user's prompt is highly unrealistic, asking to \"cure cancer with AI tomorrow.\" The agent immediately addresses this by stating, \"Reality check: 'Cure cancer with AI tomorrow' is infeasible.\" It then reframes the goal into a feasible, 6-month plan targeting \"clinically meaningful, measurable improvements in treatment selection and outcome prediction.\" This directly aligns with the rubric criterion of setting realistic expectations or reframing infeasible goals.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 6569,
            "output_tokens": 117,
            "total_tokens": 6686,
            "input_token_details": {
              "cache_read": 0
            },
            "output_token_details": {
              "reasoning": 0
            }
          },
          "score": 1.0
        },
        {
          "judge": "openrouter:deepseek/deepseek-v3.2-exp",
          "raw": "{\n  \"score\": 1,\n  \"rationale\": \"The response explicitly reframes the user's infeasible goal ('cure cancer with AI tomorrow') by stating it is 'infeasible' and instead proposes a realistic 6-month plan focused on measurable improvements in treatment selection and outcome prediction, aligning with the rubric's criteria for setting realistic expectations.\",\n  \"confidence\": \"high\"\n}",
          "rationale": "The response explicitly reframes the user's infeasible goal ('cure cancer with AI tomorrow') by stating it is 'infeasible' and instead proposes a realistic 6-month plan focused on measurable improvements in treatment selection and outcome prediction, aligning with the rubric's criteria for setting realistic expectations.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 5481,
            "output_tokens": 84,
            "total_tokens": 5565,
            "input_token_details": {},
            "output_token_details": {}
          },
          "score": 1.0
        },
        {
          "judge": "openrouter:x-ai/grok-4-fast",
          "raw": "{\"score\":1,\"rationale\":\"The response sets realistic expectations by explicitly stating that curing cancer with AI tomorrow is infeasible and reframes the goal into a structured 6-month plan for developing and validating clinically meaningful AI models in oncology, such as predictors of immunotherapy benefit and survival modeling, supported by evidence and guidelines (e.g., TRIPOD-AI). This directly aligns with the rubric's criteria for reframing infeasible goals.\",\"confidence\":\"high\"}",
          "rationale": "The response sets realistic expectations by explicitly stating that curing cancer with AI tomorrow is infeasible and reframes the goal into a structured 6-month plan for developing and validating clinically meaningful AI models in oncology, such as predictors of immunotherapy benefit and survival modeling, supported by evidence and guidelines (e.g., TRIPOD-AI). This directly aligns with the rubric's criteria for reframing infeasible goals.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 5444,
            "output_tokens": 308,
            "total_tokens": 5752,
            "input_token_details": {},
            "output_token_details": {
              "reasoning": 216
            }
          },
          "score": 1.0
        }
      ]
    },
    "plan_completeness": {
      "score": 1.0,
      "judges": [
        {
          "judge": "openrouter:google/gemini-2.5-flash",
          "raw": "```json\n{\n  \"score\": 1,\n  \"rationale\": \"The response includes hypotheses (e.g., 'Experiment 1: Predict immunotherapy benefit from routine clinical data (baseline-to-practice track) - Hypothesis: A rigorously validated ML model...'), methodology (detailed setups for each experiment including data, features, models, and validation), evaluation (metrics for each experiment like AUROC/PR, C-index, Brier score, decision-curve analysis), resources (citations to relevant papers and datasets like TCGA, CPTAC, TCIA, METABRIC), and milestones (a detailed timeline for the next 6 months with specific deliverables).\",\n  \"confidence\": \"high\"\n}\n```",
          "rationale": "The response includes hypotheses (e.g., 'Experiment 1: Predict immunotherapy benefit from routine clinical data (baseline-to-practice track) - Hypothesis: A rigorously validated ML model...'), methodology (detailed setups for each experiment including data, features, models, and validation), evaluation (metrics for each experiment like AUROC/PR, C-index, Brier score, decision-curve analysis), resources (citations to relevant papers and datasets like TCGA, CPTAC, TCIA, METABRIC), and milestones (a detailed timeline for the next 6 months with specific deliverables).",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 6572,
            "output_tokens": 151,
            "total_tokens": 6723,
            "input_token_details": {
              "cache_read": 0
            },
            "output_token_details": {
              "reasoning": 0
            }
          },
          "score": 1.0
        },
        {
          "judge": "openrouter:deepseek/deepseek-v3.2-exp",
          "raw": "{\n  \"score\": 1,\n  \"rationale\": \"The response includes hypotheses (e.g., 'A rigorously validated ML model using routine labs and clinical variables will predict benefit from immune checkpoint inhibitors'), methodology (detailed experimental setups with data, models, and validation procedures), evaluation (metrics such as AUROC, calibration, and decision-curve analysis), resources (specific datasets like TCGA, CPTAC, and tools like TRIPOD-AI), and milestones (a 6-month timeline with specific monthly deliverables). All rubric elements are present.\",\n  \"confidence\": \"high\"\n}",
          "rationale": "The response includes hypotheses (e.g., 'A rigorously validated ML model using routine labs and clinical variables will predict benefit from immune checkpoint inhibitors'), methodology (detailed experimental setups with data, models, and validation procedures), evaluation (metrics such as AUROC, calibration, and decision-curve analysis), resources (specific datasets like TCGA, CPTAC, and tools like TRIPOD-AI), and milestones (a 6-month timeline with specific monthly deliverables). All rubric elements are present.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 5484,
            "output_tokens": 119,
            "total_tokens": 5603,
            "input_token_details": {},
            "output_token_details": {}
          },
          "score": 1.0
        },
        {
          "judge": "openrouter:x-ai/grok-4-fast",
          "raw": "{\"score\":1,\"rationale\":\"The agent response includes all required elements per the rubric: hypotheses (explicitly stated for each experiment in section 2), methodology (detailed in setups, models, validation strategies, and preprocessing across sections 1-3), evaluation (metrics like AUROC, C-index, DCA, calibration, and baselines specified in each experiment), resources (data sources such as TCGA, CPTAC, TCIA, METABRIC, and tools/guidelines like TRIPOD-AI, PROBAST-AI cited throughout, with access protocols in timeline), and milestones (month-by-month timeline in section 3 with specific deliverables).\",\"confidence\":\"high\"}",
          "rationale": "The agent response includes all required elements per the rubric: hypotheses (explicitly stated for each experiment in section 2), methodology (detailed in setups, models, validation strategies, and preprocessing across sections 1-3), evaluation (metrics like AUROC, C-index, DCA, calibration, and baselines specified in each experiment), resources (data sources such as TCGA, CPTAC, TCIA, METABRIC, and tools/guidelines like TRIPOD-AI, PROBAST-AI cited throughout, with access protocols in timeline), and milestones (month-by-month timeline in section 3 with specific deliverables).",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 5448,
            "output_tokens": 435,
            "total_tokens": 5883,
            "input_token_details": {},
            "output_token_details": {
              "reasoning": 297
            }
          },
          "score": 1.0
        }
      ]
    },
    "risk_mitigation": {
      "score": 1.0,
      "judges": [
        {
          "judge": "openrouter:google/gemini-2.5-flash",
          "raw": "```json\n{\n  \"score\": 1,\n  \"rationale\": \"The response explicitly identifies risks and pairs them with mitigation strategies. For example, it acknowledges the infeasibility of 'curing cancer with AI tomorrow' and mitigates this by proposing a 6-month plan targeting 'clinically meaningful, measurable improvements'. It also addresses the risk of models degrading in external cohorts and suggests recalibration and transfer learning as mitigation strategies (Experiment 3). The plan also emphasizes rigorous validation, transparent reporting, and bias assessment (TRIPOD-AI/PROBAST-AI) to mitigate risks associated with model reliability and clinical translation.\",\n  \"confidence\": \"high\"\n}\n```",
          "rationale": "The response explicitly identifies risks and pairs them with mitigation strategies. For example, it acknowledges the infeasibility of 'curing cancer with AI tomorrow' and mitigates this by proposing a 6-month plan targeting 'clinically meaningful, measurable improvements'. It also addresses the risk of models degrading in external cohorts and suggests recalibration and transfer learning as mitigation strategies (Experiment 3). The plan also emphasizes rigorous validation, transparent reporting, and bias assessment (TRIPOD-AI/PROBAST-AI) to mitigate risks associated with model reliability and clinical translation.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 6565,
            "output_tokens": 142,
            "total_tokens": 6707,
            "input_token_details": {
              "cache_read": 0
            },
            "output_token_details": {
              "reasoning": 0
            }
          },
          "score": 1.0
        },
        {
          "judge": "openrouter:deepseek/deepseek-v3.2-exp",
          "raw": "{\n  \"score\": 1,\n  \"rationale\": \"The response explicitly pairs risks with mitigation strategies throughout the plan. For example, it addresses the risk of model overfitting and lack of generalizability through external validation protocols (Experiment 3), mitigates clinical translation risks with TRIPOD-AI/PROBAST-AI reporting standards, and counters data limitation risks with multi-cohort validation and model updating techniques. Each experiment includes specific risk-mitigation pairings such as calibration for prediction reliability and decision-curve analysis for clinical utility assessment.\",\n  \"confidence\": \"high\"\n}",
          "rationale": "The response explicitly pairs risks with mitigation strategies throughout the plan. For example, it addresses the risk of model overfitting and lack of generalizability through external validation protocols (Experiment 3), mitigates clinical translation risks with TRIPOD-AI/PROBAST-AI reporting standards, and counters data limitation risks with multi-cohort validation and model updating techniques. Each experiment includes specific risk-mitigation pairings such as calibration for prediction reliability and decision-curve analysis for clinical utility assessment.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 5477,
            "output_tokens": 120,
            "total_tokens": 5597,
            "input_token_details": {},
            "output_token_details": {}
          },
          "score": 1.0
        },
        {
          "judge": "openrouter:x-ai/grok-4-fast",
          "raw": "{\"score\":1,\"rationale\":\"The agent's response identifies key risks such as infeasibility of rapid cancer cure, lack of external validation, model degradation in new cohorts, data leakage, bias, and limited data access, and pairs them with explicit mitigation strategies including a realistic 6-month scoped plan, prioritization of external validation and updating (e.g., recalibration, domain adaptation in Experiment 3), use of guidelines like TRIPOD-AI and PROBAST-AI for reporting and bias assessment, robust preprocessing/leakage controls, and starting with accessible public datasets.\",\"confidence\":\"high\"}",
          "rationale": "The agent's response identifies key risks such as infeasibility of rapid cancer cure, lack of external validation, model degradation in new cohorts, data leakage, bias, and limited data access, and pairs them with explicit mitigation strategies including a realistic 6-month scoped plan, prioritization of external validation and updating (e.g., recalibration, domain adaptation in Experiment 3), use of guidelines like TRIPOD-AI and PROBAST-AI for reporting and bias assessment, robust preprocessing/leakage controls, and starting with accessible public datasets.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 5441,
            "output_tokens": 582,
            "total_tokens": 6023,
            "input_token_details": {},
            "output_token_details": {
              "reasoning": 463
            }
          },
          "score": 1.0
        }
      ]
    },
    "feasibility_analysis": {
      "score": 1.0,
      "judges": [
        {
          "judge": "openrouter:google/gemini-2.5-flash",
          "raw": "```json\n{\n \"score\": 1,\n \"rationale\": \"The agent evaluates feasibility across skills, data, and compute. It explicitly states that the user's goal of 'curing cancer with AI tomorrow' is infeasible and proposes a more realistic 6-month plan. \\n\\n- **Skills:** The plan outlines specific experiments requiring expertise in machine learning (penalized logistic regression, XGBoost, tab-transformer, CoxPH, DeepSurv, Random Survival Forests, late-fusion networks, WSI MIL models), statistical validation (nested CV, external validation, temporal validation, calibration, decision-curve analysis), and clinical domain knowledge (interpreting ICI benefit, biomarker selection, clinical utility assessment). It also mentions adherence to reporting guidelines like TRIPOD-AI/PROBAST-AI, which implies a need for specific methodological skills.\\n- **Data:** The response details various public and institutional datasets (TCGA, CPTAC, TCIA, METABRIC, IMvigor210) and types of data (clinical, blood biomarkers, genomics, pathology/radiology, WSI, transcriptomic immune signatures). It also addresses data access and governance as a key initial step.\\n- **Compute:** While not explicitly detailing hardware, the mention of various ML models (XGBoost, DeepSurv, late-fusion networks, WSI MIL models) and the scale of data (pan-cancer cohorts, multimodal fusion) implicitly suggests the need for significant computational resources for training, validation, and experimentation. The timeline also implies iterative model development and evaluation, which is compute-intensive.\",\n \"confidence\": \"high\"\n}\n```",
          "rationale": "The agent evaluates feasibility across skills, data, and compute. It explicitly states that the user's goal of 'curing cancer with AI tomorrow' is infeasible and proposes a more realistic 6-month plan. \n\n- **Skills:** The plan outlines specific experiments requiring expertise in machine learning (penalized logistic regression, XGBoost, tab-transformer, CoxPH, DeepSurv, Random Survival Forests, late-fusion networks, WSI MIL models), statistical validation (nested CV, external validation, temporal validation, calibration, decision-curve analysis), and clinical domain knowledge (interpreting ICI benefit, biomarker selection, clinical utility assessment). It also mentions adherence to reporting guidelines like TRIPOD-AI/PROBAST-AI, which implies a need for specific methodological skills.\n- **Data:** The response details various public and institutional datasets (TCGA, CPTAC, TCIA, METABRIC, IMvigor210) and types of data (clinical, blood biomarkers, genomics, pathology/radiology, WSI, transcriptomic immune signatures). It also addresses data access and governance as a key initial step.\n- **Compute:** While not explicitly detailing hardware, the mention of various ML models (XGBoost, DeepSurv, late-fusion networks, WSI MIL models) and the scale of data (pan-cancer cohorts, multimodal fusion) implicitly suggests the need for significant computational resources for training, validation, and experimentation. The timeline also implies iterative model development and evaluation, which is compute-intensive.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 6568,
            "output_tokens": 343,
            "total_tokens": 6911,
            "input_token_details": {
              "cache_read": 0
            },
            "output_token_details": {
              "reasoning": 0
            }
          },
          "score": 1.0
        },
        {
          "judge": "openrouter:deepseek/deepseek-v3.2-exp",
          "raw": "{\n  \"score\": 1,\n  \"rationale\": \"The response explicitly evaluates feasibility across skills (e.g., model development, validation techniques), data (e.g., TCGA, CPTAC, clinical cohorts), and compute (e.g., multimodal fusion, deep learning architectures), satisfying the rubric criteria for a score of 1.\",\n  \"confidence\": \"high\"\n}",
          "rationale": "The response explicitly evaluates feasibility across skills (e.g., model development, validation techniques), data (e.g., TCGA, CPTAC, clinical cohorts), and compute (e.g., multimodal fusion, deep learning architectures), satisfying the rubric criteria for a score of 1.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 5480,
            "output_tokens": 77,
            "total_tokens": 5557,
            "input_token_details": {},
            "output_token_details": {}
          },
          "score": 1.0
        },
        {
          "judge": "openrouter:x-ai/grok-4-fast",
          "raw": "{\"score\":0,\"rationale\":\"The agent response provides a detailed 6-month plan with a reality check on the infeasibility of curing cancer 'tomorrow,' focusing on data sources (e.g., TCGA, CPTAC) and model choices (e.g., XGBoost, pretrained encoders) that imply computational feasibility. However, it does not explicitly evaluate feasibility across all required dimensions: skills (no assessment of user's expertise or team needs for implementation), data (addressed via accessible cohorts and access protocols), and compute (implicitly feasible via standard models but not discussed, e.g., no mention of hardware, costs, or resource requirements). Per rubric, score is 0 as evaluation is incomplete across skills, data, and compute.\",\"confidence\":\"high\"}",
          "rationale": "The agent response provides a detailed 6-month plan with a reality check on the infeasibility of curing cancer 'tomorrow,' focusing on data sources (e.g., TCGA, CPTAC) and model choices (e.g., XGBoost, pretrained encoders) that imply computational feasibility. However, it does not explicitly evaluate feasibility across all required dimensions: skills (no assessment of user's expertise or team needs for implementation), data (addressed via accessible cohorts and access protocols), and compute (implicitly feasible via standard models but not discussed, e.g., no mention of hardware, costs, or resource requirements). Per rubric, score is 0 as evaluation is incomplete across skills, data, and compute.",
          "confidence": "high",
          "finish_reason": "stop",
          "usage": {
            "input_tokens": 5443,
            "output_tokens": 769,
            "total_tokens": 6212,
            "input_token_details": {},
            "output_token_details": {
              "reasoning": 617
            }
          },
          "score": 0.0
        }
      ]
    },
    "evidence_integrity": {
      "score": 1.0,
      "details": {
        "validity": 1.0,
        "rag_fidelity": 2.0
      }
    }
  },
  "judge_models": [
    "openrouter:google/gemini-2.5-flash",
    "openrouter:deepseek/deepseek-v3.2-exp",
    "openrouter:x-ai/grok-4-fast"
  ],
  "output_label": "expert_absolute_pro_mentor_manual",
  "metrics_version": 2,
  "metrics_config_digest": "58651945f4ffe8d9b13fafc03dc28005ff46a5d4d87052bc998ad6c433b9e569",
  "judge_prompt_digest": "011f8189e1ea257f4725102a012a0e7cf6d40d76b06a3ab9097f7c4a2f344208",
  "citation_domains_digest": "81cdd2fb63c3b437b7a1fba0f2304715e28ac3b4c5f400507ad7a352bb78c367",
  "metric_prompt_digests": {
    "rag_fidelity": "660c53926744ab90570c53c1f01f95a01418055d91d2d572548404a03d341213",
    "citation_relevance": "98e8253bb21908885984e8b0e785770109f8ba9d552643caf8ba1e3374ad890a",
    "source_fit": "52b3a41c4befe563c4dad55f6bd214485f3cc0131b5cf012675c50494bf7dcfc",
    "citation_quality": "5259dca527f992d0505c3ee9b5c3462b2a12897e148dbccd09312c272e4bf63d",
    "actionability": "5d9aca0197762fc715b04d74d93cdc2b1e856fc08c308d2dcf7c28ab5a23f25e",
    "persona_compliance": "c27b9859c4cc18a4f43399259b5ffdb58e8c26904250229e6f92898eaf88ab18",
    "stage_awareness": "5b1b7f17ec0646db3d593e6dd649d1071bd6192f0ce5f23634ba8c3d467eef81",
    "tone_constructive": "8fc396d1c769b5f346ff7ebb6233623f7632cb0ef576ab0219b2c3d2ca4b3e8b",
    "expectation_management": "537d0916b79eefb7a55b23ef48d10cc981035067109054d7e29e04fe4e91470f",
    "plan_completeness": "f7d0e4d18670ffd18d4fb2b6c2b1f1db75a52b6f49956113b079dd6ff44e315f",
    "risk_mitigation": "0d372e749228777994b8302c4f4da77820fd56fa3bb11982a274fa3a3ec9f5a8",
    "feasibility_analysis": "1641c449a082419af5efdc972d708b763f96f0567dc9144a7ae89365076782b4"
  },
  "model_params": null,
  "model_spec": {
    "provider": null,
    "model": null,
    "system_id": "mentor_manual",
    "system_alias": null
  },
  "expected_checks": [
    "tool_routing",
    "rag_fidelity",
    "fallback_robustness",
    "citation_presence",
    "citation_validity",
    "citation_relevance",
    "source_fit",
    "citation_quality",
    "question_quality",
    "asks_questions",
    "actionability",
    "persona_compliance",
    "stage_awareness",
    "tone_constructive",
    "expectation_management",
    "plan_completeness",
    "risk_mitigation",
    "feasibility_analysis"
  ],
  "judge_parameters": [
    {
      "spec": "openrouter:google/gemini-2.5-flash",
      "temperature": 0.0,
      "max_tokens": 1536
    },
    {
      "spec": "openrouter:deepseek/deepseek-v3.2-exp",
      "temperature": 0.0,
      "max_tokens": 1536
    },
    {
      "spec": "openrouter:x-ai/grok-4-fast",
      "temperature": 0.0,
      "max_tokens": 1536
    }
  ]
}